(Q91038198)

English

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial

scientific article published on 28 September 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Stephen Nicholls

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

12

object named as

Paul M Ridker

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

A Michael Lincoff

2

object named as

A Michael Lincoff

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

17

object named as

Steven E Nissen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

John J. P. Kastelein

7

object named as

John J P Kastelein

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Dariush Mozaffarian

10

object named as

Dariush Mozaffarian

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Christie M. Ballantyne

4

object named as

Christie M Ballantyne

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Darren K McGuire

9

object named as

Darren K McGuire

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

author name string

Dianna Bash

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Philip J Barter

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Michael H Davidson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Wolfgang Koenig

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Terje R Pedersen

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Björn W Karlson

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Torbjörn Lundström

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Kathy Wolski

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

publication date

28 September 2018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Clinical Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

41

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1281-1288

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

The forgotten majority: unfinished business in cardiovascular risk reduction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Common variants associated with plasma triglycerides and risk for coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

ANGPTL3 Deficiency and Protection Against Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Triglycerides and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

PPAR-α agonists are still on the rise: an update on clinical and experimental findings

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Niacin and heart disease prevention: Engraving its tombstone is a mistake

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of extended-release niacin with laropiprant in high-risk patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

The composition of the Eskimo food in north western Greenland

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

The Omega-3 Index: a new risk factor for death from coronary heart disease?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Omega-3 polyunsaturated fatty acids and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationships between plasma fatty acid composition and coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.23055

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CLC.23055

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30125052%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q91038198&oldid=2086452507"